TAVI용 뇌색전 방지 디바이스 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Cerebral Embolic Protection Devices for TAVI was estimated to be worth US$ 104 million in 2024 and is forecast to a readjusted size of US$ 384 million by 2031 with a CAGR of 19.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Cerebral Embolic Protection Devices for TAVI cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.

TAVI (transcatheter aortic valve implantation), as a minimally invasive treatment for high-risk elderly patients or patients with surgical risks, has become one of the important breakthroughs in the cardiovascular field in recent years. TAVI technology has not only significantly improved the safety and effectiveness of valve replacement therapy, but also greatly improved the quality of life of patients. However, there are certain risks in the TAVI operation, especially the risk of cerebral embolism, which has always been a challenge in clinical treatment. In order to effectively reduce the cerebral embolic events that may occur during TAVI surgery, cerebral embolic protection devices (CEPDs) came into being and became an important technical means to ensure the safety of TAVI treatment and patient prognosis.

At present, with the widespread application and acceptance of TAVI technology, the market demand for cerebral embolic protection devices is also growing. During TAVI surgery, especially when valve implantation is performed through the femoral artery, tiny blood clots may fall off due to the operation of the valve implanter and catheter, thereby causing cerebral embolism. This cerebral embolic event can cause stroke or other neurological complications, affecting the patient's prognosis. In order to effectively prevent this risk, CEPDs came into being and quickly became one of the standard configurations in TAVI surgery.

Brain

Globally, the European and American markets started early in the application of TAVI technology and related protection devices, and the market acceptance is high. Especially in the United States and Europe, more and more TAVI surgeries are beginning to routinely use cerebral embolic protection devices. In China and other Asian regions, with the gradual popularization of TAVI technology, the market demand for cerebral embolic protection devices is also rising. Although it is still in its infancy compared to the European and American markets, with the continuous advancement of medical technology and health concepts, the market potential is huge.

Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.

This report aims to provide a comprehensive presentation of the global market for Cerebral Embolic Protection Devices for TAVI, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cerebral Embolic Protection Devices for TAVI by region & country, by Type, and by Application.

The Cerebral Embolic Protection Devices for TAVI market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cerebral Embolic Protection Devices for TAVI.

Market Segmentation

By Company

• Boston Scientific (Claret Medical)
• Venus Medtech (Keystone Heart)
• Transverse Medical
• Emboline
• Protembis GmbH
• Filterlex Medical

Segment by Type

• Total Artery Coverage
• Non-total Artery Coverage

Segment by Application

• Hopsital
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cerebral Embolic Protection Devices for TAVI manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Cerebral Embolic Protection Devices for TAVI in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Cerebral Embolic Protection Devices for TAVI in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Cerebral Embolic Protection Devices for TAVI Product Introduction
• 1.2 Global Cerebral Embolic Protection Devices for TAVI Market Size Forecast
  • 1.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value (2020-2031)
  • 1.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume (2020-2031)
  • 1.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Price (2020-2031)
• 1.3 Cerebral Embolic Protection Devices for TAVI Market Trends & Drivers
  • 1.3.1 Cerebral Embolic Protection Devices for TAVI Industry Trends
  • 1.3.2 Cerebral Embolic Protection Devices for TAVI Market Drivers & Opportunity
  • 1.3.3 Cerebral Embolic Protection Devices for TAVI Market Challenges
  • 1.3.4 Cerebral Embolic Protection Devices for TAVI Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Cerebral Embolic Protection Devices for TAVI Players Revenue Ranking (2024)
• 2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Company (2020-2025)
• 2.3 Global Cerebral Embolic Protection Devices for TAVI Players Sales Volume Ranking (2024)
• 2.4 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Company Players (2020-2025)
• 2.5 Global Cerebral Embolic Protection Devices for TAVI Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Cerebral Embolic Protection Devices for TAVI Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Cerebral Embolic Protection Devices for TAVI Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Cerebral Embolic Protection Devices for TAVI
• 2.9 Cerebral Embolic Protection Devices for TAVI Market Competitive Analysis
  • 2.9.1 Cerebral Embolic Protection Devices for TAVI Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Cerebral Embolic Protection Devices for TAVI Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebral Embolic Protection Devices for TAVI as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Total Artery Coverage
  • 3.1.2 Non-total Artery Coverage
• 3.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type
  • 3.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Type (2020-2031)
  • 3.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Type (%) (2020-2031)
• 3.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type
  • 3.3.1 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Cerebral Embolic Protection Devices for TAVI Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hopsital
  • 4.1.2 Others
• 4.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application
  • 4.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Application (2020-2031)
  • 4.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Application (%) (2020-2031)
• 4.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application
  • 4.3.1 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Cerebral Embolic Protection Devices for TAVI Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region
  • 5.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2020-2025)
  • 5.1.3 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2026-2031)
  • 5.1.4 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (%), (2020-2031)
• 5.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region
  • 5.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2020-2025)
  • 5.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2026-2031)
  • 5.2.4 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (%), (2020-2031)
• 5.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 5.4.2 North America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 5.5.2 Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 5.7.2 South America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 6.3.2 United States Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 6.4.2 Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 6.5.2 China Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 6.6.2 Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 6.7.2 South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
  • 6.9.2 India Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Boston Scientific (Claret Medical)
  • 7.1.1 Boston Scientific (Claret Medical) Company Information
  • 7.1.2 Boston Scientific (Claret Medical) Introduction and Business Overview
  • 7.1.3 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product Offerings
  • 7.1.5 Boston Scientific (Claret Medical) Recent Development
• 7.2 Venus Medtech (Keystone Heart)
  • 7.2.1 Venus Medtech (Keystone Heart) Company Information
  • 7.2.2 Venus Medtech (Keystone Heart) Introduction and Business Overview
  • 7.2.3 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product Offerings
  • 7.2.5 Venus Medtech (Keystone Heart) Recent Development
• 7.3 Transverse Medical
  • 7.3.1 Transverse Medical Company Information
  • 7.3.2 Transverse Medical Introduction and Business Overview
  • 7.3.3 Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Transverse Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
  • 7.3.5 Transverse Medical Recent Development
• 7.4 Emboline
  • 7.4.1 Emboline Company Information
  • 7.4.2 Emboline Introduction and Business Overview
  • 7.4.3 Emboline Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Emboline Cerebral Embolic Protection Devices for TAVI Product Offerings
  • 7.4.5 Emboline Recent Development
• 7.5 Protembis GmbH
  • 7.5.1 Protembis GmbH Company Information
  • 7.5.2 Protembis GmbH Introduction and Business Overview
  • 7.5.3 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product Offerings
  • 7.5.5 Protembis GmbH Recent Development
• 7.6 Filterlex Medical
  • 7.6.1 Filterlex Medical Company Information
  • 7.6.2 Filterlex Medical Introduction and Business Overview
  • 7.6.3 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
  • 7.6.5 Filterlex Medical Recent Development

8 Industry Chain Analysis

• 8.1 Cerebral Embolic Protection Devices for TAVI Industrial Chain
• 8.2 Cerebral Embolic Protection Devices for TAVI Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Cerebral Embolic Protection Devices for TAVI Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Cerebral Embolic Protection Devices for TAVI Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer